Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

This study has been completed.
Royal University Hospital Foundation
Information provided by:
University of Saskatchewan Identifier:
First received: January 18, 2008
Last updated: January 6, 2009
Last verified: July 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):